Clinical Paper: Effects of Infant Formula with Human Milk Oligosaccharides on Growth and Morbidity

In a randomised multicenter trial by Puccio et al. 2017, it demonstrates that infant formula with 2'FL and LNnT is safe, well-tolerated, and supports age-appropriate growth. Secondary outcome findings show associations between consuming HMO-supplemented formula and lower parent-reported morbidity (particularly bronchitis) and medication use (antipyretics and antibiotics).